Cite

HARVARD Citation

    Benz, R. et al. (2020). Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis. Leukemia & lymphoma. 61 (10), pp. 2533-2535. [Online]. 
  
Back to record